Pharmapedia

Cardiac Stent : Current market scenario and further price cut

  • Posted on: 21 February 2018
  • By: admin

Indian Price regulator, NPPA has again reduced Cardiac stent prices after they price capped for around 85% in last year February 2017. Before price capped, bare metal stents (BMS) were used to be sold for Rs45,000 and drug-eluting stents (DES) for Rs1.2 lakhs. Well, in Feb 2017 their prices are reduced to 7400 and 30180, respectively. And obviously, companies dealing with stents were baffled and left with no clue. This article will discuss the market scenario in India after price cap up to recent time. The broad discussion is going on whether to include DES in speacial category of stent and allow manufacturers to drive more prices from it.


NEXUS BETWEEN MEDICAL HEALTHCARE PROFESSIONALS AND PHARMACEUTICAL COMPANIES : BOON OR BANE FOR PATIENTS

ABOUT AUHTORS
BALVINDER SINGH*1, PAWAN JALWAL 1, VIKASH KUMAR RUHIL 2
1Shri Baba Mastnath Institute of Pharmaceutical Sciences & Research,
Baba Mastnath University, Asthal Bohar, Rohtak, Haryana, India
2P.D.M. College of Pharmacy, P.D.M. University, Bahadurgarh, Haryana, India

*balvindersinghpharmaco@gmail.com

ABSTRACT
What started as imparting education to medical healthcare professionals, regarding pharmaceutical products by various pharmaceutical companies, has now become a grave, giant problem in the category of bribery and to be more precise, corruption in this 21st century. Now detailing of pharmaceutical company product has included giving free physician’s sample packs, prescription pads, pen and includes an entire range of latest electronic gazettes of mobile phones, laptops, tablets, AC, Refrigerator, LED TV, sponsoring a conference, refreshment to all expenses like return air ticket with free boarding and lodging in national or international tourist spot or hilly area. The real problem is that nothing comes free; all these expenses will add to cost of medicines and medical fraternity will heed least to quality of medicine. Now the market is flooded with abundant, spurious, sub-standard medicines; as pharmaceutical companies have the confidence of selling these products by shelling huge, attractive offers/gifts to some of greedy doctors, who fall prey to their lucrative offers. In this article, the aim is to probe this association or rather; we can call nexus between the medical healthcare professionals and various pharmaceutical companies. Various aspects are covered in this article, like….How this association works? What is the modus operandi and rationale of this association? Various angles of this association; from medical healthcare professionals, medical councils, pharmaceutical companies and society point of views are covered.


BANKRUPTCY IN PHARMACEUTICALS

ABOUT AUHTORS
Rajesh Vagh
PharmaTutor Edu Labs
Surat, Gujarat
rajesh@pharmatutor.org

Bankruptcy may be a new term or less familiar with most of you but it is of higher importance. Bankruptcy is a legal status of a person or other entity that cannot repay debts to creditors. We may consider it as a white-collar fraud. First let me clear that bankrupt can be defined as different act in various jurisdiction but generally  bankruptcy statutes involve concealment of assets, concealment or destruction of documents, conflicts of interest, fraudulent claims, false statements or declarations, and fee fixing or redistribution arrangements etc.  Bankruptcy fraud is a federal crime in the USA and India.


HOW WOULD A NATION LIKE INDIA BEAR EXPENSES OF INSULINS AND NON-INSULIN ANTI-DIABETICS IN COMING YEARS?

ABOUT AUHTOR
Amit Gangwal
Director, Arogya Retail
Indore, MP, India
Gangwal.amit@gmail.com

Perhaps insulin is the only molecule or medicinal molecule which has helped scientist/s to claim Nobel Prize at least for 3 times. Frederick Banting & J.J.R. Macleod were awarded with Nobel Prize in 1923 for the discovery of insulin. Another Nobel, in 1958, went into the account of British molecular biologist Frederick Sanger for determining the primary structure of insulin. Rosalyn Sussman Yalow was selected for Nobel of 1977 for the development of the radioimmunoassay for insulin.


SPERMICIDAL CONDOM AND RISK OF URINARY TRACT INFECTION IN FEMALE

{ DOWNLOAD AS PDF }

ABOUT AUHTOR
Priyatama V. Powar
Pharmaceutics Department
Dr. D. Y. Patil College of Pharmacy,
Akurdi, Pune-44
priyatama.powar@gmail.com

Urinary Tract Infections are common health problems in clinical practice in all age groups both male and female cause by bacteria that affects urinary system. Occurrence and frequency of Urinary Tract Infection is higher in female as compare to male because of mainly following reasons


HOW DIGITALIZATION CAN BE UTILIZED FOR BETTER MARKETING & SALES IN PHARMACEUTICALS

ABOUT AUHTOR
Rajesh Vagh
PharmaTutor Edu Labs
Surat, Gujarat, India

So far, medical representatives are assets for pharma sales but need of time and competitions are asking for variant ways to promote their products. Patient portals, apps and online communities should be developed with more intensity and utilize technologies to improve customer experience.


IS THE CHEMOTHERAPY REALLY NECESSARY FOR SOLID TUMORS?

{ DOWNLOAD AS PDF }

ABOUT AUHTOR
Dr. Vishwas B. Chavan
Aditya Jyot Hospital & Foundation
vishwaschavan2003@yahoo.co.in

Cancer is a leading cause of morbidity and mortality in the world today. According to one study, there were 14.1 million new cases of cancer and 8.2 million cancer-related deaths worldwide in 2012. The most commonly diagnosed cancers were lung (1.82 million), breast (1.67 million), and colorectal (1.36 million). The most common cancer deaths are due to lung cancer (1.6 million deaths), liver cancer (745,000 deaths), and stomach cancer (723,000 deaths) (Ferlay, J. et al, 2015).


GATEWAYS TO DRUG ABUSE: A BRIEF REPORT ON PUNJAB & HARYANA

ABOUT AUHTORS
Piyush Tripathi*,  Abhishek Arora
GMSCL,
GUJARAT(INDIA)
*piyushtripathi1992@rediffmail.com

Drug addiction is a serious problem in one country that is known for its culture, traditions & social values all over the world. The country where people commit suicide either because of love affairs or due to drug addiction related issues. Undoubtedly, this writing is talking about India.


APPEARING IN B.PHARMACY EXAMINATION ( SESSIONAL/ SEMESTER END/ YEAR END FINAL EXAMINATION) : AN ART OR SCIENCE?

{ DOWNLOAD AS PDF }

ABOUT AUHTORS
BALVINDER SINGH1*, PAWAN JALWAL 1, VIKASH KUMAR RUHIL 2, NEHA MINOCHA1
1.Department of Pharmaceutical Sciences & Research, Baba Mastnath University, Asthal Bohar, Rohtak, Haryana, India
2. P.D.M. College of Pharmacy, Bahadurgarh, Haryana, India
balvindersinghpharmaco@gmail.com

ABSTRACT
B.Pharmacy course is one of the leading professional courses in India. Two types of examinations are prevalent in B.Pharmacy course. One is the sessional examinations for internal evaluation. Second is the semester end/year end examination. Each examination has its own importance. The student should be well prepared for appearing in the examination. Appearing in the B.Pharm. Examination is not only merely science but it requires amalgamation of science and art.


Pages